SLI
2.019,59
PKT
+11,20
PKT
+0,56
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
10.04.18 | Nestlé market-perform | Bernstein Research | |
10.04.18 | Givaudan Underperform | Bernstein Research | |
10.04.18 | Givaudan buy | Baader Bank | |
10.04.18 | Givaudan Neutral | UBS AG | |
10.04.18 | Novartis Underperform | Credit Suisse Group | |
10.04.18 | Novartis Hold | Deutsche Bank AG | |
10.04.18 | Swiss Re overweight | Barclays Capital | |
09.04.18 | Novartis buy | S&P Capital IQ | |
09.04.18 | Novartis Outperform | Bernstein Research | |
09.04.18 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
09.04.18 | Novartis Halten | Independent Research GmbH | |
09.04.18 | Novartis Neutral | UBS AG | |
09.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
09.04.18 | Novartis buy | Baader Bank | |
09.04.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
08.04.18 | UBS Sector Perform | RBC Capital Markets | |
08.04.18 | UBS kaufen | RBC Capital Markets | |
06.04.18 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
06.04.18 | ABB (Asea Brown Boveri) Neutral | Citigroup Corp. | |
06.04.18 | UBS overweight | JP Morgan Chase & Co. | |
06.04.18 | UBS overweight | JP Morgan Chase & Co. | |
05.04.18 | Swiss Re Sell | UBS AG | |
05.04.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
05.04.18 | Swiss Re buy | Deutsche Bank AG | |
05.04.18 | UBS Hold | Deutsche Bank AG | |
05.04.18 | UBS buy | Deutsche Bank AG | |
05.04.18 | Nestlé buy | Goldman Sachs Group Inc. | |
04.04.18 | Swiss Re Sell | UBS AG | |
04.04.18 | Swiss Re buy | Baader Bank | |
04.04.18 | Nestlé Outperform | RBC Capital Markets | |
03.04.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
03.04.18 | Roche overweight | JP Morgan Chase & Co. | |
03.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
03.04.18 | Nestlé Neutral | UBS AG | |
03.04.18 | UBS buy | UBS AG | |
29.03.18 | Zurich Insurance Neutral | UBS AG | |
29.03.18 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
29.03.18 | Swiss Re overweight | Barclays Capital | |
29.03.18 | Swiss Re Sector Perform | RBC Capital Markets | |
29.03.18 | Roche Hold | Deutsche Bank AG |